With headquarters in Vienna, Austria, Biomedica Immunoassays provides internationally recognized, high-quality ELISA assays for clinical studies in cardiovascular diseases, bone metabolism, nephrology and transplantation. Our clients include pharmaceutical companies, CROs and numerous top ranking scientific institutions worldwide. With our deep expertise, global network of distributors, customised solutions and commitment to personalised service, Biomedica Immunoassays provides the optimal immunoassay solution for clinical trials.

Biomarker ELISA assays

Biomedica´s ELISA assays cover a full panel of unique and well-established biomarkers used in clinical trials. In the field of bone metabolism and CKD – MBD, our markers range from free sRANKL, Osteoprotegerin, DKK-1, and Periostin to FGF23, Sclerostin, and Endostatin, respectively. Our cardiorenal markers include a wide panel of natriuretic peptides (NT-proBNP, proANP, and NT-proCNP) as well as Big Endothelin, Endothelin, and C4D.

Setting the standard for clinical research

Biomedica dedicates its efforts in setting the standard for clinical research and provides complete ready-to-use ELISA kits for superior performance and reproducibility. All assays are fully validated assays according to ICH guidelines. The kits include serum-based standards and controls, thus allowing investigators to collect biologically reliable data.

Strategic partner

Our strategic partner for research and development is ‘The Antibody Lab GmbH (TAL)’, located in Vienna, Austria. The company’s know-how and intellectual property in antibody engineering, protein expression and assay development is the key success for developing cutting edge biomarker ELISA assays. Based on this cooperation, Biomedica manufactures and markets immunoassays for clinical research worldwide.

Technical and scientific support

Biomedica’s experienced and qualified team of professionals is recognized by its outstanding technical and scientific support. The company´s clients appreciate its responsiveness, personal involvement and passion.

CE marked ELISA assays – ready for use in IVD

The majority of Biomedica’s assays are CE marked and ready for use in IVD. The company’s manufacturing processes comply with ISO 9001:2008 management system standards and conform to GMP/GLP guidelines. All reagents are also offered in bulk or in customized quantities.

Biomedica Immunoassays maintains distribution operations worldwide.

Please use the form below to send us your business enquiry.